Anti-EST4A/ CES4A/ CES6 functional antibody

Anti-EST4A/ CES4A/ CES6 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CES4A/CES4A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0760-Ab-1/ GM-Tg-hg-SE0760-Ab-2Anti-Human CES4A monoclonal antibodyHuman
GM-Tg-rg-SE0760-Ab-1/ GM-Tg-rg-SE0760-Ab-2Anti-Rat CES4A monoclonal antibodyRat
GM-Tg-mg-SE0760-Ab-1/ GM-Tg-mg-SE0760-Ab-2Anti-Mouse CES4A monoclonal antibodyMouse
GM-Tg-cynog-SE0760-Ab-1/ GM-Tg-cynog-SE0760-Ab-2Anti-Cynomolgus/ Rhesus macaque CES4A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0760-Ab-1/ GM-Tg-felg-SE0760-Ab-2Anti-Feline CES4A monoclonal antibodyFeline
GM-Tg-cang-SE0760-Ab-1/ GM-Tg-cang-SE0760-Ab-2Anti-Canine CES4A monoclonal antibodyCanine
GM-Tg-bovg-SE0760-Ab-1/ GM-Tg-bovg-SE0760-Ab-2Anti-Bovine CES4A monoclonal antibodyBovine
GM-Tg-equg-SE0760-Ab-1/ GM-Tg-equg-SE0760-Ab-2Anti-Equine CES4A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0760-Ab-1/ GM-Tg-hg-SE0760-Ab-2; GM-Tg-rg-SE0760-Ab-1/ GM-Tg-rg-SE0760-Ab-2;
GM-Tg-mg-SE0760-Ab-1/ GM-Tg-mg-SE0760-Ab-2; GM-Tg-cynog-SE0760-Ab-1/ GM-Tg-cynog-SE0760-Ab-2;
GM-Tg-felg-SE0760-Ab-1/ GM-Tg-felg-SE0760-Ab-2; GM-Tg-cang-SE0760-Ab-1/ GM-Tg-cang-SE0760-Ab-2;
GM-Tg-bovg-SE0760-Ab-1/ GM-Tg-bovg-SE0760-Ab-2; GM-Tg-equg-SE0760-Ab-1/ GM-Tg-equg-SE0760-Ab-2
Products NameAnti-CES4A monoclonal antibody
Formatmab
Target NameCES4A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CES4A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0760-Ag-1Recombinant multi-species EST4A/ CES4A/ CES6 protein


    Target information

    Target IDGM-SE0760
    Target NameCES4A
    Gene ID283848,234677,291955,697791,101087285,529706
    Gene Symbol and SynonymsCES4A,CES6,CES8,RGD1307418
    Uniprot AccessionQ5XG92,P0C6R3
    Uniprot Entry NameEST4A_HUMAN,EST4A_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000172824
    Target ClassificationN/A

    The target: CES4A, gene name: CES4A, also named as CES6, CES8. This gene encodes a member of the carboxylesterase large family. The family members are responsible for the hydrolysis or transesterification of various xenobiotics, such as cocaine and heroin, and endogenous substrates with ester, thioester, or amide bonds. They also participate in fatty acyl and cholesterol ester metabolism, and may play a role in the blood-brain barrier system. This gene, also called CES6, encodes a secreted enzyme, and may play a role in the detoxification of drugs and xenobiotics in neural and other tissues of the body and in the cerebrospinal fluid. Multiple transcript variants encoding different isoforms have been reported, but the full-length nature and/or biological validity of some variants have not been determined. [provided by RefSeq, Jun 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.